HOTCHKIS & WILEY's SNY Position Overview
HOTCHKIS & WILEY (via Hotchkis & Wiley Capital Management LLC) currently holds 1.94 M shares of Sanofi (SNY) worth $93.93 M, representing 0.28% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, HOTCHKIS & WILEY has maintained a long-term strategic position in SNY, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2014, adding 3.89 M shares. Largest reduction occurred in Q2 2017, reducing 4.54 M shares.
Analysis based on 13F filings available since 2013 Q2
HOTCHKIS & WILEY's Sanofi (SNY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Sanofi (SNY) Trades by HOTCHKIS & WILEY
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +336,900 | Add 21.04% | 1.94 M | $48.46 |
| Q3 2025 | -576,398 | Reduce 26.47% | 1.6 M | $47.20 |
| Q2 2025 | -32,291 | Reduce 1.46% | 2.18 M | $48.31 |
| Q1 2025 | -47,980 | Reduce 2.12% | 2.21 M | $55.46 |
| Q4 2024 | -454 | Reduce 0.02% | 2.26 M | $48.23 |
| Q3 2024 | -31,120 | Reduce 1.36% | 2.26 M | $57.63 |
| Q2 2024 | +4,761 | Add 0.21% | 2.29 M | $48.52 |
| Q1 2024 | +7,314 | Add 0.32% | 2.28 M | $48.60 |
| Q4 2023 | -59,530 | Reduce 2.55% | 2.28 M | $49.73 |
| Q3 2023 | -24,020 | Reduce 1.02% | 2.34 M | $53.64 |
| Q2 2023 | -12,900 | Reduce 0.54% | 2.36 M | $53.90 |
| Q1 2023 | -88,250 | Reduce 3.58% | 2.37 M | $54.42 |
| Q4 2022 | -123,150 | Reduce 4.76% | 2.46 M | $48.43 |
| Q3 2022 | -1.15 M | Reduce 30.84% | 2.59 M | $38.02 |
| Q2 2022 | -763,899 | Reduce 16.97% | 3.74 M | $50.03 |
| Q1 2022 | -244,500 | Reduce 5.15% | 4.5 M | $51.34 |
| Q4 2021 | -146,565 | Reduce 3.00% | 4.75 M | $50.10 |
| Q3 2021 | -205,100 | Reduce 4.02% | 4.89 M | $48.21 |
| Q2 2021 | -378,098 | Reduce 6.90% | 5.1 M | $52.66 |
| Q1 2021 | +77,600 | Add 1.44% | 5.48 M | $49.46 |
| Q4 2020 | +1.87 M | Add 53.14% | 5.4 M | $48.59 |
| Q3 2020 | +49,300 | Add 1.42% | 3.53 M | $50.17 |
| Q2 2020 | +123,400 | Add 3.68% | 3.48 M | $51.05 |
| Q1 2020 | -98,300 | Reduce 2.85% | 3.35 M | $43.72 |
| Q4 2019 | +337,755 | Add 10.85% | 3.45 M | $50.20 |
| Q3 2019 | -132,500 | Reduce 4.08% | 3.11 M | $46.33 |
| Q2 2019 | +4,200 | Add 0.13% | 3.25 M | $43.27 |
| Q1 2019 | -1.63 M | Reduce 33.52% | 3.24 M | $44.28 |
| Q4 2018 | -1.18 M | Reduce 19.46% | 4.88 M | $43.41 |
| Q3 2018 | -76,058 | Reduce 1.24% | 6.05 M | $44.67 |
| Q2 2018 | -216,000 | Reduce 3.40% | 6.13 M | $40.01 |
| Q1 2018 | +547,100 | Add 9.43% | 6.35 M | $40.08 |
| Q4 2017 | -64,900 | Reduce 1.11% | 5.8 M | $43.00 |
| Q3 2017 | +38,597 | Add 0.66% | 5.86 M | $49.79 |
| Q2 2017 | -4.54 M | Reduce 43.79% | 5.83 M | $47.91 |
| Q1 2017 | -974,300 | Reduce 8.59% | 10.36 M | $45.25 |
| Q4 2016 | -702,383 | Reduce 5.83% | 11.34 M | $40.44 |
| Q3 2016 | +608,916 | Add 5.33% | 12.04 M | $38.19 |
| Q2 2016 | +1.27 M | Add 12.47% | 11.43 M | $41.85 |
| Q1 2016 | +23,611 | Add 0.23% | 10.16 M | $40.16 |
| Q4 2015 | +1.11 M | Add 12.24% | 10.14 M | $42.65 |
| Q3 2015 | -1.67 M | Reduce 15.57% | 9.04 M | $47.47 |
| Q2 2015 | -1.08 M | Reduce 9.17% | 10.7 M | $49.53 |
| Q1 2015 | +89,487 | Add 0.77% | 11.78 M | $49.44 |
| Q4 2014 | +1.8 M | Add 18.16% | 11.69 M | $45.61 |
| Q3 2014 | +123,460 | Add 1.26% | 9.9 M | $56.43 |
| Q2 2014 | -32,533 | Reduce 0.33% | 9.77 M | $53.17 |
| Q1 2014 | +3.89 M | Add 65.83% | 9.8 M | $52.28 |
| Q4 2013 | +1.13 M | Add 23.53% | 5.91 M | $53.63 |
| Q3 2013 | +1.15 M | Add 31.71% | 4.79 M | $50.63 |
| Q2 2013 | +3.63 M | Add 0.00% | 3.63 M | $51.51 |
HOTCHKIS & WILEY's Sanofi Investment FAQs
HOTCHKIS & WILEY first purchased Sanofi (SNY) in Q2 2013, acquiring 3,633,907 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
HOTCHKIS & WILEY has held Sanofi (SNY) for 51 quarters since Q2 2013.
HOTCHKIS & WILEY's largest addition to Sanofi (SNY) was in Q1 2014, adding 9,804,594 shares worth $512.58 M.
According to the latest 13F filing for Q4 2025, HOTCHKIS & WILEY's firm, Hotchkis & Wiley Capital Management LLC, owns 1,938,207 shares of Sanofi (SNY), valued at approximately $93.93 M.
As of the Q4 2025 filing, Sanofi (SNY) represents approximately 0.28% of HOTCHKIS & WILEY's publicly disclosed stock portfolio, making it one of their key holdings.
HOTCHKIS & WILEY's peak holding in Sanofi (SNY) was 12,041,028 shares, as reported at the end of Q3 2016.